Dolby Laboratories (US.DLB)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.DLB · YoY: 2026 9M vs 2025 9M
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 77.4% | ↓ |
| ROE | 6.8% | ↓ |
| Cash Conversion | 178.0% | → |
| D/E Ratio | 0.02 | ↓ |
| Gross Margin | 87.8% | → |
US.DLB (Dolby Laboratories) | YoY: 2026 9M vs 2025 9M Metric Value YoY ---------------------------- FCF Conversion 77.4% ↓ ROE 6.8% ↓ Cash Conversion 178.0% → D/E Ratio 0.02 ↓ Gross Margin 87.8% →
Key Metrics
US.DLB (Dolby Laboratories) | YoY: 2026 9M vs 2025 9M
Metric Value YoY----------------------------FCF Conversion 77.4% ↓ROE 6.8% ↓Cash Conversion 178.0% →D/E Ratio 0.02 ↓Gross Margin 87.8% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies